Simplex Trading’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-900
| Closed | -$3K | – | 11310 |
|
|
2022
Q2 | $3K | Sell |
900
-600
| -40% | -$2.37K | ﹤0.01% | 9258 |
|
|
2022
Q1 | $5K | Buy |
+1,500
| New | +$4.75K | ﹤0.01% | 9490 |
|
|
2021
Q4 | – | Sell |
-7,900
| Closed | -$32K | – | 11784 |
|
|
2021
Q3 | $32K | Hold |
7,900
| – | – | ﹤0.01% | 8047 |
|
|
2021
Q2 | $33K | Buy |
7,900
+7,837
| +12,440% | +$33.2K | ﹤0.01% | 8157 |
|
|
2021
Q1 | $31K | Buy |
+63
| New | +$509 | ﹤0.01% | 7103 |
|
|
2020
Q1 | – | Sell |
-74
| Closed | -$68K | – | 8499 |
|
|
2019
Q4 | $68K | Sell |
74
-5
| -6% | -$35 | ﹤0.01% | 4915 |
|
|
2019
Q3 | $46K | Buy |
79
+49
| +163% | +$520 | ﹤0.01% | 5099 |
|
|
2019
Q2 | $36K | Buy |
+30
| New | +$323 | ﹤0.01% | 5139 |
|
|
2018
Q3 | – | Sell |
-120
| Closed | -$201K | – | 8289 |
|
|
2018
Q2 | $201K | Buy |
+120
| New | +$2.33K | ﹤0.01% | 3484 |
|
|
2017
Q4 | – | Sell |
-403
| Closed | -$36K | – | 6922 |
|
|
2017
Q3 | $36K | Buy |
403
+3
| +0.8% | +$44 | ﹤0.01% | 2608 |
|
|
2017
Q2 | $111K | Buy |
400
+330
| +471% | +$4.86K | ﹤0.01% | 1667 |
|
|
2017
Q1 | $18K | Buy |
+70
| New | +$840 | ﹤0.01% | 3377 |
|
Simplex Trading's CNCE Position: Q1 2023 in Review
Simplex Trading sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 5,789 shares — an estimated $33K sold.
Simplex Trading first reported a position in CNCE in Q4 2015 and held it in 20 quarters. The position peaked at $222K in Q3 2017. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.
- Simplex Trading reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Simplex Trading sold 5,789 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $33K.
- Simplex Trading first reported a position in Concert Pharmaceuticals, Inc. in Q4 2015 and held it in 20 quarters.
- Simplex Trading's Concert Pharmaceuticals, Inc. position peaked at $222K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.
Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.